BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11367584)

  • 21. [The radiologic study of the nasolacrimal duct decompression surgery for treatment of chronic].
    Li XH; Liu ZX; Wang P; Yang G; Ma SB
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 31(4):290-292. PubMed ID: 29871244
    [No Abstract]   [Full Text] [Related]  

  • 22. Study on the effectiveness of antibiotic prophylaxis in external dacryocystorhinostomy: a review of 697 cases.
    Pinar-Sueiro S; Fernández-Hermida RV; Gibelalde A; Martínez-Indart L
    Ophthalmic Plast Reconstr Surg; 2010; 26(6):467-72. PubMed ID: 21099383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteriology and antibiotic therapy in congenital nasolacrimal duct obstruction.
    Kuchar A; Lukas J; Steinkogler FJ
    Acta Ophthalmol Scand; 2000 Dec; 78(6):694-8. PubMed ID: 11167236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lacrimal excretory system concretions: canalicular and lacrimal sac.
    Repp DJ; Burkat CN; Lucarelli MJ
    Ophthalmology; 2009 Nov; 116(11):2230-5. PubMed ID: 19744730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of indocyanine green gel in the identification and complete removal of the medial wall of the lacrimal sac during endoscopic endonasal dacryocystorhinostomy.
    Park J; Lee J; Lee H; Baek S
    Can J Ophthalmol; 2017 Oct; 52(5):494-498. PubMed ID: 28985810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Routine histopathologic evaluation of the lacrimal sac during dacryocystorhinostomy: how useful is it?
    Bernardini FP; Moin M; Kersten RC; Reeves D; Kulwin DR
    Ophthalmology; 2002 Jul; 109(7):1214-7; discussion 1217-8. PubMed ID: 12093640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rosenmüller valve during endoscopic dacryocystorhinostomy in treating refractory nasolacrimal duct obstruction].
    Wang M; Wang SQ; Zhang J; Li MW; Xing ZM; Yuan XP; Li H; Liu Y; Geng CL
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jul; 51(7):522-7. PubMed ID: 27480301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viral nucleic acid analysis with PCR in lacrimal tissue and nasal swab samples of primary acquired nasolacrimal duct obstruction cases.
    Yanık Ö; Hoşal B; Tekeli A; Nalcı H
    Eur J Ophthalmol; 2021 Jan; 31(1):138-143. PubMed ID: 31630558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lacrimal sac bacteriology and susceptibility pattern in infants with congenital nasolacrimal duct obstruction in the 1st year of life: a cross-sectional study.
    Zheng XY; Choy BNK; Zhou MM; Shi CP; Zhao ZY
    BMC Pediatr; 2020 Oct; 20(1):465. PubMed ID: 33023519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pathogenesis and treatment of lacrimal obstruction: The value of lacrimal sac and bone analysis.
    DeAngelis D; Hurwitz J; Oestreicher J; Howarth D
    Orbit; 2001 Sep; 20(3):163-172. PubMed ID: 12045908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoscopic-assisted retrieval of retained lacrimal stent material in congenital nasolacrimal duct obstruction without dacryocystorhinostomy.
    Ng DS; Chan E; Tong FM; Chow SK; Ko ST
    Orbit; 2016; 35(2):103-5. PubMed ID: 26838355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbiological patterns of chronic dacryocystitis.
    Badhu BP; Karki BS; Khanal B; Dulal S; Das H
    Ophthalmology; 2006 Dec; 113(12):2377.e1-2. PubMed ID: 17157151
    [No Abstract]   [Full Text] [Related]  

  • 33. [Masquerade lacrimal duct stenosis: prevalence of lacrimal sac tumors].
    Mihailovic N; Steenken J; Elges S; Merté RL; Grenzebach U; Eter N; Alnawaiseh M
    Ophthalmologe; 2020 May; 117(5):439-444. PubMed ID: 31520115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dacryocystorhinostomy for dacryocystitis caused by methicillin- resistant Staphylococcus aureus: report of four cases.
    Kubo M; Sakuraba T; Arai Y; Nakazawa M
    Jpn J Ophthalmol; 2002; 46(2):177-82. PubMed ID: 12062223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of functional epiphora in patients with an anatomically patent dacryocystorhinostomy.
    Shams PN; Chen PG; Wormald PJ; Sloan B; Wilcsek G; McNab A; Selva D
    JAMA Ophthalmol; 2014 Sep; 132(9):1127-32. PubMed ID: 24903661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacteriology of chronic dacryocystitis in adult population of northeast India.
    Das JK; Deka AC; Kuri GC; Bhattacharjee K; Das D; Gogoi K
    Orbit; 2008; 27(4):243-7. PubMed ID: 18716961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavior and outcomes of 70 adult lacrimal sac mucoceles.
    Nayak A; Ali MJ; Tripathy D; Mohapatra S; Bansal O; Rath S
    Orbit; 2021 Jun; 40(3):228-232. PubMed ID: 32434405
    [No Abstract]   [Full Text] [Related]  

  • 38. Functional metagenomic profile of the lacrimal sac microbial communities in primary acquired nasolacrimal duct obstruction: The Lacriome paper 2.
    Ali MJ
    Eur J Ophthalmol; 2022 Jul; 32(4):2059-2066. PubMed ID: 34816752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of Bacterial Samples from Patients with Chronic Acquired Nasolacrimal Duct Obstruction.
    Zvornicanin J
    Med Arch; 2017 Feb; 71(1):76. PubMed ID: 28428681
    [No Abstract]   [Full Text] [Related]  

  • 40. [Recanalization of nasolacrimal duct with radio frequency: preliminary study].
    Garcia EA; Machado MA; Silva JA; Nosé W
    Arq Bras Oftalmol; 2012; 75(6):412-4. PubMed ID: 23715144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.